Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9FD8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,586
Award facts
- Contract value 100% obligated
- $50,586.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $50.6K delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on December 10, 2025, with completion scheduled for December 11, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Dupixent is a biologic medication commonly prescribed for conditions including moderate-to-severe eczema, asthma, and chronic rhinosinusitis, reflecting the Defense Logistics Agency's role in supplying specialized pharmaceutical products for military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, valued at $999.9 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for federal military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical procurement contracts predominantly with the Defense Logistics Agency, supplying brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9FD8?
SPE2DR26F9FD8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F9FD8 worth?
The government has obligated $50,586 on SPE2DR26F9FD8.
Is contract SPE2DR26F9FD8 an order under another contract?
Yes. SPE2DR26F9FD8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9FD8 competed?
The extent of competition for SPE2DR26F9FD8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award